Cargando…
Oxaliplatin and Infliximab Combination Synergizes in Inducing Colon Cancer Regression
BACKGROUND: Colon cancer is one of the most common malignant cancers and causes millions of deaths each year. There are still no effective treatments for colon cancer patients who are at advanced stage. Tumor necrosis factor-alpha (TNF-α) might be a good therapy target due to its widely-accepted rol...
Autores principales: | Li, Wenya, Xu, Jian, Zhao, Jian, Zhang, Rui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5319445/ https://www.ncbi.nlm.nih.gov/pubmed/28190020 http://dx.doi.org/10.12659/MSM.901880 |
Ejemplares similares
-
Oxaliplatin and infliximab synergize to induce regression of colon cancer
por: Huang, Di, et al.
Publicado: (2018) -
Long Noncoding RNA Plasmacytoma Variant Translocation 1 (PVT1) Promotes Colon Cancer Progression via Endogenous Sponging miR-26b
por: Zhang, Rui, et al.
Publicado: (2018) -
Circulating Biomarkers for Predicting Infliximab Response in Rheumatoid Arthritis: A Systematic Bioinformatics Analysis
por: Huang, Qiu-lan, et al.
Publicado: (2017) -
Capilliposide C Sensitizes Esophageal Squamous Carcinoma Cells to Oxaliplatin by Inducing Apoptosis Through the PI3K/Akt/mTOR Pathway
por: Shen, Zhipeng, et al.
Publicado: (2017) -
Taxol-Resistant Gene 1 (Txr1) Mediates Oxaliplatin Resistance by Inducing Autophagy in Human Nasopharyngeal Carcinoma Cells
por: Chi, Hua-ming, et al.
Publicado: (2019)